FIELD: medicine, medicinal industry. SUBSTANCE: invention relates to using peptide of the formula: Lys-Glu-Glu- Leu-Asn-Glu as an agent stimulating proliferation of fibroblasts. Peptide Lys-Glu-Glu-Leu-Asn- -Glu is able to stimulate proliferation of fibroblasts in 50-fold less doses that shows its enhanced specific activity and gives the possibility for reduction of adverse effect risk. The proposed agent can be used as a stimulating agent of processes of proliferation in different pathology requiring activation of regenerative potential and provides the enhancement of biological activity. EFFECT: enhanced effectiveness, valuable medicinal properties of agent. 3 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
PREPARATION STIMULATING THE DIFFERENTIATION OF T-LYMPHOCYTES | 2001 |
|
RU2188032C1 |
METHOD FOR STIMULATING MDBK CELL CULTURE METABOLISM FOR VIRUS REPRODUCTION | 2019 |
|
RU2715336C1 |
AGENT ELICITING IMMUNOSTIMULATING ACTIVITY | 2000 |
|
RU2177803C1 |
AGENT STIMULATING ANTIGEN-NONDEPENDING DIFFERENTIATION OF LYMPHOCYTE B | 2000 |
|
RU2166956C1 |
METHODS FOR CELL CULTIVATION AND SETS AND DEVICE FOR THEM | 2016 |
|
RU2761557C2 |
METHODS, SETS, MEANS AND DEVICES FOR TRANSDUCTION | 2016 |
|
RU2761555C2 |
METHODS FOR CULTIVATION OF CELLS AND SETS AND DEVICE FOR THEM | 2016 |
|
RU2778411C2 |
COMPOSITIONS AND METHODS FOR THE TREATMENT OF AUTOIMMUNE DISEASES AND CANCER | 2016 |
|
RU2761980C2 |
PEPTIDES SHOWING REGENERATIVE-REPARATIVE ACTION | 1994 |
|
RU2065445C1 |
INHIBITORS OF CD95 SIGNALING PATHWAY FOR TREATMENT OF MDS | 2013 |
|
RU2652348C2 |
Authors
Dates
2003-08-27—Published
2002-01-08—Filed